Literature DB >> 7942079

Serum profiles of oxytocin during oral contraceptive treatment.

S Stock1, R Karlsson, B von Schoultz.   

Abstract

Serum profiles of oxytocin were studied by means of a continuous blood sampling system in five young healthy women before and during treatment with a combined oral contraceptive. Oxytocin levels were determined by a specific radioimmunoassay in blood samples collected in 10-min fractions from 22.00 to 06.00. The values were further analyzed by the pulse detection program PULSAR. Great individual differences in oxytocin profiles were observed, and in some of the women these differences were also pronounced between the two sampling occasions. All 10 profiles demonstrated irregular peaks which occurred with varying frequency. Although the baseline level of oxytocin increased in all women and the average concentration increased in four of the women during treatment, there was no clear-cut effect on the peak frequency. Based on results from animal experiments, it is suggested that the increase in oxytocin levels may be related to an excitatory effect exerted by estrogen on oxytocin secreting neurons.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Desogestrel; Developed Countries; Endocrine System; Ethinyl Estradiol; Europe; Examinations And Diagnoses; Family Planning; Hematologic Tests; Hormones; Laboratory Examinations And Diagnoses; Laboratory Procedures; Northern Europe; Oral Contraceptives; Oral Contraceptives, Combined; Oxytocin; Physiology; Pituitary Hormones; Research Report; Scandinavia; Sweden

Mesh:

Substances:

Year:  1994        PMID: 7942079     DOI: 10.3109/09513599409058033

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  7 in total

1.  Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.

Authors:  Kai Macdonald; David Feifel
Journal:  Acta Neuropsychiatr       Date:  2011-12-19       Impact factor: 3.403

2.  Are You Morally Modified?: The Moral Effects of Widely Used Pharmaceuticals.

Authors:  Neil Levy; Thomas Douglas; Guy Kahane; Sylvia Terbeck; Philip J Cowen; Miles Hewstone; Julian Savulescu
Journal:  Philos Psychiatr Psychol       Date:  2014-06-01

3.  Oxytocin levels are lower in premenopausal women with type 1 diabetes mellitus compared with matched controls.

Authors:  Amber S Kujath; Lauretta Quinn; Mary E Elliott; Krista A Varady; Tamara J LeCaire; C Sue Carter; Kirstie K Danielson
Journal:  Diabetes Metab Res Rev       Date:  2014-09-03       Impact factor: 4.876

4.  Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits.

Authors:  Morris Goldman; Megan Marlow-O'Connor; Ivan Torres; C S Carter
Journal:  Schizophr Res       Date:  2007-10-24       Impact factor: 4.939

5.  Hormonal contraceptives, menstrual cycle and brain response to faces.

Authors:  Klara Marecková; Jennifer S Perrin; Irum Nawaz Khan; Claire Lawrence; Erin Dickie; Doug A McQuiggan; Tomás Paus
Journal:  Soc Cogn Affect Neurosci       Date:  2012-11-21       Impact factor: 3.436

6.  Moral Enhancement, Freedom and the God Machine.

Authors:  Julian Savulescu; Ingmar Persson
Journal:  Monist       Date:  2012-07

7.  Early posttraumatic autonomic and endocrine markers to predict posttraumatic stress symptoms after a preventive intervention with oxytocin.

Authors:  Sinha Engel; Mirjam van Zuiden; Jessie L Frijling; Saskia B J Koch; Laura Nawijn; Rinde L W Yildiz; Sarah Schumacher; Christine Knaevelsrud; Jos A Bosch; Dick J Veltman; Miranda Olff
Journal:  Eur J Psychotraumatol       Date:  2020-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.